SCHEMBL27433034

CO[C@H]1OC(COS(=O)(=O)O)[C@@H](O[C@@H]2OC(C(=O)O)[C@@H](O[C@H]3OC(COS(=O)(=O)O)[C@@H](O[C@@H]4OC(C(=O)O)[C@@H](O[C@H]5OC(COS(=O)(=O)O)[C@@H](O[C@@H]6OC(C(=O)O)[C@@H](O[C@H]7OC(COS(=O)(=O)O)[C@@H](O[C@@H]8OC(C(=O)O)[C@@H](O[C@H]9OC(COS(=O)(=O)O)[C@@H](O)[C@H](O)C9N)[C@H](O)C8O)[C@H](O)C7N)[C@H](O)C6O)[C@H](O)C5N)[C@H](O)C4O)[C@H](O)C3N)[C@H](O)C2O)[C@H](O)C1N

nearest known ligand 0.61

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	F10	P00742	6/20	0.61

▸	SERPINC1	P01008	3/20	0.49

▸	BDNF	P23560	3/20	0.46

▸	PTN	P21246	2/20	0.46

▸	MDK	P21741	2/20	0.46

▸	FGF1	P05230	3/20	0.45

▸	F2	P00734	1/20	0.40

▸	HPSE	Q9Y251	2/20	0.39

▸	PF4	P02776	1/20	0.39

▸	BLM	P54132	1/20	0.38

▸	RECQL	P46063	1/20	0.38

▸	TDP1	Q9NUW8	1/20	0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL27433042	0.92	F10 (0.55)	F10SERPINC1BDNFPTNMDK
SCHEMBL14817755	0.92	F10 (0.69)	F10SERPINC1BDNFPTNMDK
SCHEMBL15171284	0.92	F10 (0.69)	F10SERPINC1BDNFPTNMDK
SCHEMBL19619414	0.92	F10 (0.69)	F10SERPINC1BDNFPTNMDK
SCHEMBL15296510	0.89	F10 (0.65)	F10SERPINC1BDNFPTNMDK
SCHEMBL15171262	0.89	F10 (0.65)	F10SERPINC1BDNFPTNMDK
SCHEMBL15325002	0.88	F10 (0.52)	F10SERPINC1BDNFPTNMDK
SCHEMBL13796405	0.85	F10 (0.62)	F10SERPINC1BDNFPTNMDK
SCHEMBL16418343	0.85	F10 (0.58)	F10SERPINC1BDNFPTNMDK
SCHEMBL10148982	0.85	F10 (0.62)	F10SERPINC1BDNFPTNMDK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240216419-A1	SULFATED OLIGOSACCHARIDES HAVING ANTI-INFLAMMATORY ACTIVITY	THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US)	2024-07-04	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20240216419-A1	SULFATED OLIGOSACCHARIDES HAVING ANTI-INFLAMMATORY ACTIVITY	HMGB1, HPSE, HMGB2	F10 1454/4885SERPINC1 160/4885BDNF 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.